105 related articles for article (PubMed ID: 11751591)
1. Ligands have various potential effects on the degradation of pregnane X receptor by proteasome.
Masuyama H; Inoshita H; Hiramatsu Y; Kudo T
Endocrinology; 2002 Jan; 143(1):55-61. PubMed ID: 11751591
[TBL] [Abstract][Full Text] [Related]
2. Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors.
Masuyama H; Hiramatsu Y
J Biol Chem; 2004 Mar; 279(13):12020-6. PubMed ID: 14702340
[TBL] [Abstract][Full Text] [Related]
3. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the AF-2 domain of VDR.
Masuyama H; MacDonald PN
J Cell Biochem; 1998 Dec; 71(3):429-40. PubMed ID: 9831079
[TBL] [Abstract][Full Text] [Related]
4. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription.
Masuyama H; Hiramatsu Y; Kunitomi M; Kudo T; MacDonald PN
Mol Endocrinol; 2000 Mar; 14(3):421-8. PubMed ID: 10707959
[TBL] [Abstract][Full Text] [Related]
5. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion.
Masuyama H; Suwaki N; Tateishi Y; Nakatsukasa H; Segawa T; Hiramatsu Y
Mol Endocrinol; 2005 May; 19(5):1170-80. PubMed ID: 15650019
[TBL] [Abstract][Full Text] [Related]
6. Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1.
Su K; Yang X; Roos MD; Paterson AJ; Kudlow JE
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):281-9. PubMed ID: 10816420
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of transcription, proteasome inhibitors, and DNA-damaging drugs differentially affect feedback of p53 degradation.
An WG; Chuman Y; Fojo T; Blagosklonny MV
Exp Cell Res; 1998 Oct; 244(1):54-60. PubMed ID: 9770348
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus early region 1A protein binds to mammalian SUG1-a regulatory component of the proteasome.
Grand RJ; Turnell AS; Mason GG; Wang W; Milner AE; Mymryk JS; Rookes SM; Rivett AJ; Gallimore PH
Oncogene; 1999 Jan; 18(2):449-58. PubMed ID: 9927201
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes.
Blanquart C; Barbier O; Fruchart JC; Staels B; Glineur C
J Biol Chem; 2002 Oct; 277(40):37254-9. PubMed ID: 12118000
[TBL] [Abstract][Full Text] [Related]
10. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression.
Roth A; Looser R; Kaufmann M; Blättler SM; Rencurel F; Huang W; Moore DD; Meyer UA
Mol Pharmacol; 2008 Apr; 73(4):1282-9. PubMed ID: 18187584
[TBL] [Abstract][Full Text] [Related]
11. Implication of the ubiquitin/proteasome system in Myc-regulated transcription.
von der Lehr N; Johansson S; Larsson LG
Cell Cycle; 2003; 2(5):403-7. PubMed ID: 12963825
[TBL] [Abstract][Full Text] [Related]
12. Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators.
Yan F; Gao X; Lonard DM; Nawaz Z
Mol Endocrinol; 2003 Jul; 17(7):1315-31. PubMed ID: 12663742
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
Milligan SA; Owens MW; Grisham MB
Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation by p38MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation.
Giannì M; Bauer A; Garattini E; Chambon P; Rochette-Egly C
EMBO J; 2002 Jul; 21(14):3760-9. PubMed ID: 12110588
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome pathway is required for the function of the viral VP16 transcriptional activation domain.
Zhu Q; Yao J; Wani G; Chen J; Wang QE; Wani AA
FEBS Lett; 2004 Jan; 556(1-3):19-25. PubMed ID: 14706819
[TBL] [Abstract][Full Text] [Related]
16. Orphan nuclear receptor binding site in the human inducible nitric oxide synthase promoter mediates responsiveness to steroid and xenobiotic ligands.
Toell A; Kröncke KD; Kleinert H; Carlberg C
J Cell Biochem; 2002; 85(1):72-82. PubMed ID: 11891851
[TBL] [Abstract][Full Text] [Related]
17. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
Boudjelal M; Voorhees JJ; Fisher GJ
Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
[TBL] [Abstract][Full Text] [Related]
18. Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription?
Nawaz Z; O'Malley BW
Mol Endocrinol; 2004 Mar; 18(3):493-9. PubMed ID: 14673136
[TBL] [Abstract][Full Text] [Related]
19. Lactacystin, an inhibitor of the proteasome, blocks the degradation of a mutant precursor of glycosylphosphatidylinositol-linked protein in a pre-Golgi compartment.
Oda K; Ikehara Y; Omura S
Biochem Biophys Res Commun; 1996 Feb; 219(3):800-5. PubMed ID: 8645261
[TBL] [Abstract][Full Text] [Related]
20. Ligand-activated platelet-derived growth factor beta-receptor is degraded through proteasome-dependent proteolytic pathway.
Mori S; Kanaki H; Tanaka K; Morisaki N; Saito Y
Biochem Biophys Res Commun; 1995 Dec; 217(1):224-9. PubMed ID: 8526915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
